IL13 and Arthritis: In an adjuvant-induced rat model of arthritis, IL-13 therapy reduced inflammation, vascularization, and bony destruction [56], while in an immune-complex-mediated arthritis mouse model, IL-13 overexpression diminished both chondrocyte death and MMP-mediated cartilage destruction, even though joint inflammation was enhanced [57].